iohexol has been researched along with Bright Disease in 2 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JR | 1 |
Solomon, RJ | 1 |
Smets, PM | 1 |
Lefebvre, HP | 1 |
Aresu, L | 1 |
Croubels, S | 1 |
Haers, H | 1 |
Piron, K | 1 |
Meyer, E | 1 |
Daminet, S | 1 |
2 other studies available for iohexol and Bright Disease
Article | Year |
---|---|
Contrast-induced nephropathy morbidity and mortality following percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Contrast Media; Female; Glomerulonephritis; Humans; Iohexol; Male | 2009 |
Renal function and morphology in aged Beagle dogs before and after hydrocortisone administration.
Topics: Animals; Atrophy; Biopsy; Creatinine; Disease Models, Animal; Dogs; Enzyme-Linked Immunosorbent Assa | 2012 |